Xilio Therapeutics Inc. (XLO)
NASDAQ: XLO
· Real-Time Price · USD
0.70
-0.00 (-0.38%)
At close: Aug 15, 2025, 3:59 PM
0.70
-0.74%
After-hours: Aug 15, 2025, 06:54 PM EDT
Xilio Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 9.27M | 6.34M | 7.52M | 5.26M | 2.9M | 2.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | 449K | 909K | 1.4M | 1.9M | 1.94M | 1.95M | 1.91M | 1.85M | 1.75M | 1.66M | 1.59M | 1.5M | 1.1M | 723K | 350K |
Gross Profit | 9.27M | 6.34M | 7.07M | 4.35M | 1.5M | 1M | -1.94M | -1.95M | -1.91M | -1.85M | -1.75M | -1.66M | -1.59M | -1.5M | -1.1M | -723K | -350K |
Operating Income | -56.95M | -60.58M | -65.08M | -67.68M | -73.09M | -79.13M | -84.17M | -87.02M | -91.45M | -89.15M | -85.54M | -81.29M | -79.75M | -75.04M | -76.08M | -74.75M | -63.19M |
Interest Income | n/a | n/a | 100K | 100K | 100.2K | 100.2K | 200.00 | 200.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -54.3M | -58.24M | -62.8M | -65.53M | -70.96M | -76.4M | -81.22M | -84.26M | -89.52M | -88.22M | -85.46M | -81.92M | -80.49M | -75.8M | -76.87M | -75.44M | -63.77M |
Net Income | -54.3M | -58.24M | -62.8M | -65.53M | -70.96M | -75.03M | -79.14M | -81.76M | -87.02M | -87.23M | -85.17M | -82.05M | -80.61M | -75.8M | -76.87M | -75.44M | -63.77M |
Selling & General & Admin | 27.15M | 24.78M | 24.21M | 24.21M | 25.29M | 26.55M | 28.77M | 29.63M | 31.04M | 29.95M | 29.98M | 28.3M | 25.26M | 23.86M | 18.58M | 16.25M | 13.29M |
Research & Development | 39.08M | 41.21M | 44.11M | 44.4M | 46.41M | 52.14M | 55.4M | 57.38M | 60.41M | 59.2M | 55.56M | 52.99M | 54.49M | 51.19M | 57.5M | 58.49M | 49.9M |
Other Expenses | -11K | 937K | 937K | 1.59M | 2.32M | 2.25M | 2.96M | 2.76M | 1.94M | 927K | 81K | -625K | -738K | -756K | -788K | -498K | -324K |
Operating Expenses | 66.22M | 66.93M | 69.25M | 69.59M | 72.64M | 78.68M | 84.17M | 87.02M | 91.45M | 89.15M | 85.54M | 81.29M | 79.75M | 75.04M | 76.08M | 74.75M | 63.25M |
Interest Expense | n/a | n/a | 100K | 300K | 500K | 500K | 400K | 200K | n/a | 129K | 129K | 129K | 129K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | 5.94M | 5.94M | 5.94M | 5.94M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 66.22M | 66.93M | 69.7M | 70.04M | 73.09M | 79.13M | 84.17M | 87.02M | 91.45M | 89.15M | 85.54M | 81.29M | 79.75M | 75.04M | 76.08M | 74.75M | 63.25M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -1.38M | -2.08M | -2.5M | -2.5M | -988K | -287K | 129K | 129K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 74.7M | 64.68M | 63.47M | 57.76M | 27.91M | 27.56M | 27.52M | 27.47M | 27.43M | 27.42M | 27.4M | 27.38M | 27.37M | 20.06M | 26.67M | 26.67M | 26.67M |
Shares Outstanding (Diluted) | 74.7M | 64.68M | 63.47M | 57.76M | 27.91M | 27.56M | 27.52M | 27.47M | 27.43M | 27.42M | 27.4M | 27.38M | 27.37M | 20.06M | 26.67M | 26.67M | 26.67M |
EPS (Basic) | -0.84 | -1.28 | -1.72 | -2.11 | -2.57 | -2.73 | -2.88 | -2.98 | -3.18 | -3.18 | -3.37 | -3.27 | -3.24 | -3.09 | -2.89 | -2.84 | -29.97 |
EPS (Diluted) | -0.84 | -1.28 | -1.72 | -2.11 | -2.57 | -2.73 | -2.88 | -2.98 | -3.18 | -3.18 | -3.37 | -3.27 | -3.24 | -3.09 | -2.89 | -2.84 | -29.95 |
EBITDA | -55.26M | -58M | -61.85M | -64.33M | -69.73M | -76.66M | -82.23M | -85.06M | -89.55M | -87.3M | -83.79M | -79.63M | -78.16M | -73.55M | -74.64M | -73.36M | -61.96M |
EBIT | -56.96M | -59.65M | -63.57M | -66.13M | -71.57M | -78.56M | -84.17M | -87.02M | -91.45M | -89.15M | -85.54M | -81.29M | -79.75M | -75.04M | -76.08M | -74.75M | -63.25M |
Depreciation & Amortization | 1.7M | 1.64M | 1.72M | 1.8M | 1.84M | 1.9M | 1.94M | 1.95M | 1.91M | 1.85M | 1.75M | 1.66M | 1.59M | 1.5M | 1.45M | 1.38M | 1.28M |